Welcome to our dedicated page for Decibel Cannabis news (Ticker: DBCCF), a resource for investors and traders seeking the latest updates and insights on Decibel Cannabis stock.
Decibel Cannabis Company Inc. reports news on its Canadian branded cannabis business, including adult-use products, premium cannabis and extract manufactured products, and global medical exports. The company’s portfolio includes General Admission, Qwest and Standard Issue, supported by Canadian cultivation, processing and manufacturing facilities, including an EU GMP licensed cultivation and processing facility in Chatham, Ontario.
Recurring updates cover quarterly and annual financial results, domestic brand performance, international sales, AgMedica integration, credit facilities, stock option grants, shareholder meeting results and other governance matters.
Decibel Cannabis Company (OTCQB: DBCCF, TSXV: DB) confirmed that its previously approved 15:1 consolidation of issued and outstanding common shares is now effective as of market open on September 1, 2026. Trading on a post-consolidation basis on the TSX Venture Exchange is expected to commence at market open the same day, under the same company name and trading symbols, but with a new CUSIP number.
No fractional shares will be issued, with any fractions rounded down to the nearest whole share. Registered shareholders will receive a letter of transmittal from Odyssey Trust Company with instructions to exchange pre-consolidation share certificates or DRS statements for post-consolidation holdings, while non-registered shareholders must follow procedures set by their intermediaries.
Decibel (OTCQB: DBCCF) reported record Q2 2026 results, with net revenue of $35.6 million, up 19% year over year. International sales rose 72% to $10.6 million, gross margin before fair value adjustments reached 51%, adjusted EBITDA was $7.8 million (+24% YoY) and free cash flow was $4.9 million (+122% YoY).
According to the company, full-year 2026 guidance was raised to $132–$137 million in net revenue and $28–$32 million in adjusted EBITDA. Decibel announced a 15:1 share consolidation, reducing outstanding shares from about 577.0 million to approximately 38.5 million, subject to TSXV acceptance, with post-consolidation trading expected around September 1, 2026. The company is also considering a Normal Course Issuer Bid and appointed Shawn Dym as Executive Chairman, with Nadia Vattovaz as Lead Independent Director.
Decibel Cannabis Company (OTCQB: DBCCF) will release its second quarter 2026 financial results pre-market on Thursday, August 20, 2026. Management will host a live conference call at 10:00 a.m. MDT the same day to review and discuss the results.
According to Decibel, Canadian participants can join by dialing 1-800-715-9871 and U.S. participants by dialing 1-888-880-3330, using conference ID 6188739, or by accessing the online registration link. Decibel highlights its branded cannabis products, international medical exports, and facilities in Alberta, Saskatchewan and Ontario.
Decibel (OTCQB:DBCCF) reported Q1 2026 net revenue of $29.8M, up 41% year over year, with international sales rising 330% to $9.6M and domestic sales up 7% to $20.3M. Adjusted EBITDA reached $6.9M and gross margin before fair value adjustments was 51%.
Q2 2026 net revenue guidance is $33–35M, and full‑year 2026 guidance is $130–135M net revenue and $27–31M Adjusted EBITDA. Decibel closed a new $61M ATB credit facility and agreed to sell its Creston cultivation property for $2.5M, expected to save about $4M annually.
Decibel Cannabis (OTCQB:DBCCF) will release its first quarter 2026 financial results pre-market on Thursday, May 21, 2026. Management will host a live conference call at 10:00 a.m. MST the same day, with phone and online registration options available for participants.
Decibel (OTCQB: DBCCF) reported 2025 net revenue of $112.7M, up 22%, with Adjusted EBITDA $23.2M (+29%) and Free Cash Flow $5.5M (+292%). International sales rose to $24.2M (+484%). Decibel issued 2026 guidance: revenue $130–135M and Adjusted EBITDA $27–31M, and closed a new $61M credit facility in February 2026.
Decibel Cannabis Company (OTCQB: DBCCF) will report Q4 2025 financial results pre-market on April 16, 2026. A live conference call is scheduled at 10:00 a.m. MDT the same day with Canadian and U.S. dial-ins and conference ID 6569457.
Decibel describes itself as a Canadian branded cannabis manufacturer with consumer brands General Admission, Qwest and Standard Issue and facilities in Calgary, Battleford and Chatham (EU GMP licensed).
Decibel Cannabis Company (OTCQB: DBCCF) entered a conditional agreement to sell its Creston, British Columbia property for approximately $2,500,000 and will consolidate the Creston cultivation facility into its Battleford, Saskatchewan site.
The company said proceeds will repay part of its term debt, the transaction aims to generate $4 million in annual cost savings, is expected to close in April 2026, and is intended to improve production efficiency and strengthen the balance sheet.
Decibel Cannabis Company (OTCQB: DBCCF) granted an aggregate of 11,537,223 stock options effective after market close on February 10, 2026. Each Option is exercisable for one common share at $0.10 per share, the TSXV closing price on February 10, 2026.
The grant is a normal-course, long-term compensation and retention measure. Options vest in three equal annual installments on Jan 1, 2027, 2028 and 2029 and expire on Feb 10, 2031. The company operates cultivation and processing facilities across Canada and sells branded products domestically and beginning international expansion.
Decibel Cannabis (OTCQB: DBCCF) closed a $61 million credit package with ATB Financial, comprising a $40M first lien term, $10M revolver (with $3M available at close) and an $11M second lien term. Maturities were extended to February 2030, and 2026 payment obligations were reduced by $5M. Management said the financing improves free cash flow, removes near-term material maturities, maintains a debt/EBITDA ratio below 2.0x, and supports corporate development and international growth.